Fighting pancreatic cancer with immunotherapy
Researchers at the School of Medicine in St. Louis and Rush University in Chicago have found a compound that promotes a vigorous immune assault on pancreatic cancer. The findings, in mice, suggest a way to improve immunotherapy for the deadly disease in patients.
Biomarker predicts which pancreatic cysts may become cancerous
Research led by investigators at the School of Medicine has taken a step toward identifying the cysts in the pancreas that are likely to become cancerous.
Proton therapy for cancer lowers risk of side effects
A new study led by the School of Medicine has found that proton therapy is associated with fewer severe side effects than conventional X-ray radiation therapy for many cancer patients.
Centene and Washington University collaborate to advance personalized medicine research
Centene Corp. and the School of Medicine announced a partnership April 8 to transform and accelerate research into treatments for Alzheimer’s disease, breast cancer, diabetes and obesity. As part of the partnership, Centene will fund up to $100 million over 10 years in research at the university.
The End of the Beginning
Cancer, Immunity and the Future of a Cure
A fascinating history of our understanding and the treatment of cancer by one of the leading figures in the field—who is also a pioneer on the cusp of a breakthrough.
‘Jumping genes’ drive many cancers
Mistakes in DNA are known to drive cancer growth. But a new study, from Washington University School of Medicine in St. Louis, heavily implicates a genetic phenomenon commonly known as “jumping genes” in the growth of tumors.
Drug target identified for chemotherapy-resistant ovarian, breast cancer
Researchers at the School of Medicine may have found a path toward improving the effectiveness of chemotherapy in people with breast or ovarian cancer caused by defects in one of the BRCA genes. The researchers identified a pair of genes that operate in parallel to BRCA and may increase susceptibility to chemotherapy drugs.
Novel imaging technology may help reduce biopsies for breast tumors
Scientists at Washington University in St. Louis plan to use a new imaging technique to get a better look at breast tumors and reduce unnecessary biopsies.
$9 million supports deep dive into breast, pancreatic cancers
The School of Medicine has received a $9 million grant from the National Institutes of Health (NIH) to study the life histories of breast and pancreatic cancers. The grant is part of the NIH’s Human Tumor Atlas Network, a large-scale effort to better understand tumors.
$20 million gift boosts multiple myeloma research
A $20 million gift from Paula C. and Rodger O. Riney will help researchers at Washington University School of Medicine in St. Louis develop new treatments for multiple myeloma.
Older Stories